Expression of Toll-like receptors 2, 3, 4, 6, 9, and MD-2 in the normal equine cornea, limbus, and conjunctiva

Veterinary Ophthalmology

Volumn 14, Issue 2, 2011, Pages 80-85

  Gornik, Kara ^a   Moore, Phillip ^a   Figueiredo, Monica ^a   Vandenplas, Michel ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Cornea; Equine; Innate immune response; Keratitis; TLRs

Indexed keywords

PROTEIN MD 2; TOLL LIKE RECEPTOR;

ANIMAL; ARTICLE; CONJUNCTIVA; CORNEA LIMBUS; GENE EXPRESSION REGULATION; GENETICS; HORSE; METABOLISM; PHYSIOLOGY;

ANIMALS; CONJUNCTIVA; GENE EXPRESSION REGULATION; HORSES; LIMBUS CORNEAE; LYMPHOCYTE ANTIGEN 96; TOLL-LIKE RECEPTORS;

EQUIDAE;

EID: 79952143793     PISSN: 14635216     EISSN: 14635224     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2010.00844.x     Document Type: Article

References (49)

1. Guo H, Wu X, Yu FS et al. Toll-like receptor 2 mediates the induction of IL-10 in corneal fibroblasts in response to Fusarium solu. Immunology and Cell Biology 2008; 86: 271-276.
2. Brooks DE, Matthews AG. Equine ophthalmology. In: Veterinary Ophthalmology, 4th edn. (ed. Gelatt KN) Blackwell Publishing, Ames, 2007; 1203.
3. Martin CL. Cornea and sclera. In: Ophthalmic Diseases in Veterinary Medicine. (ed. Martin CL) Manson Publishing Ltd, London, 2005; 254-256.
4. Zhao J, Wu X. Triggering of toll-like receptors 2 and 4 by Aspergillus fumigatus conidia in immortalized human corneal epithelial cells to induce inflammatory cytokines. Chinese Medical Journal 2008; 5: 450-454.
5. Jin X, Qin Q, Lin Z et al. Expression of toll-like receptors in the Fusarium solani infected cornea. Current Eye Research 2008; 33: 319-324.
6. Yuan X, Mitchell BM, Wilhelmus KR. Gene profiling and signaling pathways of Candida albicans keratitis. Molecular Vision 2008; 14: 1792-1798.
7. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annual Review of Immunology 2003; 21: 335-376.
8. Jin X, Qin Q, Chen W et al. Expression of Toll-like receptors in the healthy and herpes simplex virus-infected cornea. Cornea 2007; 26: 847-852.
9. Bonini S, Micera A, Iovieno A et al. Expression of toll-like receptors in healthy and allergic conjunctiva. Ophthalmology 2005; 112: 1528e1-1528e8.
10. Chang JH, McCluskey PJ, Wakefield D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. British Journal of Ophthalmology 2006; 90: 103-108.
11. Vinistin A, Iliev DB, Monks BG et al. MD-2. Immunobiology 2006; 211: 437-447.
12. Miyake K. Endotoxin recognition molecules, Toll-like receptor-4-MD-2. Seminars in Immunology 2004; 16: 11-16.
13. Vinistin A, Mazzoni A, Spitzer JA et al. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to toll-like receptor 4. Proceedings of the National Academy of Sciences of the United States of America 2001; 98: 12156-12161.
14. Viriyakosol S, Tobias PS, Kitchens RL et al. MD-2 binds to bacterial lipopolysaccharide. The Journal of Biological Chemistry 2001; 276: 38044-38051.
15. Matthews AG. An overview of recent developments in corneal immunobiology: potential relevance in the etiogenesis of corneal disease in the horse. Veterinary Ophthalmology 2008; 11: 66-76.
16. Lohmann KL, Vandenplas ML, Barton MH et al. The equine TLR4/MD-2 complex mediates recognition of lipopolysaccharide from Rhodobacter sphaeroides as an agonist. Journal of Endotoxin Research 2007; 13: 235-242.
17. Micera A, Stampachiacchiere B, Aronni S et al. Toll-like receptors and the eye. Current Opinion in Allergy and Clinical Immunology 2005; 5: 451-458.
18. Hornung V, Rothenfusser S, Britsch S et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. The Journal of Immunology 2002; 168: 4531-4537.
19. Jin X, Qin Q, Zhou X et al. Toll-like receptors (TLRs) expression and function in response to inactivate hyphae of Fusarium solani in immortalized human corneal epithelial cells. Molecular Vision 2007; 13: 1953-1961.
20. Zhang G, Ghosh S. Toll-like receptor-mediated NF-κB activation: a phylogenetically conserved paradigm in innate immunity. The Journal of Clinical Investigation 2001; 107: 13-19.
21. Ueta M. Innate immunity of the ocular surface and ocular surface inflammatory disorders. Cornea 2008; 27(suppl. 1): S31-S40.
22. Li J, Shen JB, Beuerman RW. Expression of toll-like receptors in human limbal and conjunctival epithelial cells. Molecular Vision 2007; 13: 813-822.
23. Yu FX, Hazlett LD. Toll-like receptors and the eye. Investigative Ophthalmology & Visual Science 2006; 47: 1255-1263.
24. Ozinsky A, Underhill DM, Fontenot JD et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proceedings of the National Academy of Sciences of the United States of America 2000; 97: 13766-13771.
25. Netea MG, Warris A, Van der Meer JWM et al. Aspergillus fumigates evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. The Journal of Infectious Diseases 2003; 188: 320-326.
26. Netea MG, Van der Graaf CAA, Vonk AG et al. The roll of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. The Journal of Infectious Diseases 2002; 185: 1483-1489.
27. Netea MG, Sutmuller R, Hermann C et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. The Journal of Immunology 2004; 172: 3712-3718.
28. Takeuchi O, Kawai T, Mühlradt PF et al. Discrimination of bacterial lipoproteins by toll-like receptor 6. International Immunology 2001; 13: 933-940.
29. Pearce JW, Giuliano EA, Moore CP. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with the inclusion of the new antifungal agent voriconazole. Veterinary Ophthalmology 2009; 12: 318-324.
30. Weinstein WL, Moore PA, Sanchez S et al. In vitro efficacy of a buffered chelating solution as an antimicrobial potentiator for antifungal drugs against fungal pathogens obtained from horses with mycotic keratitis. American Journal of Veterinary Research 2006; 67: 562-568.
31. Kumagai N, Fukuda K, Fujitsu Y et al. Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. Investigative Ophthalmology Visual Science 2005; 46: 114-120.
32. Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
33. Wang JE, Warris A, Ellingsen EA et al. Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infection and Immunity 2001; 69: 2402-2406.
34. Gioannini TL, Teghanemt A, Zhang D et al. Isolation of an endotoxin-MD-2 complex that produces toll-like receptor 4-dependent cell activation at picomolar concentrations. Proceedings of the National Academy of Sciences of the United States of America 2004; 101: 4186-4191.
35. Blais DR, Vascotto SG, Griffith M et al. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells. Investigative Ophthalmology & Visual Science 2005; 46: 4235-4244.
36. Kumar A, Yu FS. Toll-like receptors and corneal innate immunity. Current Molecular Medicine 2006; 6: 327-337.
37. Tabeta K, Georgel P, Janssen E et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proceedings of the National Academy of Sciences of the United States of America 2004; 101: 3516-3521.
38. Alexopoulou L, Czopik Holt A, Medzhitov R et al. Recognition of double-stranded RNA and activation of NF-κB by toll-like receptor 3. Nature 2001; 413: 732-738.
39. Kumar A, Zhang J, Yu FX. Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells. Immunology 2005; 117: 11-21.
40. Ueta M, Hamuro J, Kiyono H et al. Triggering of TLR3 by polyI:C in human corneal epithelial cells to induce inflammatory cytokines. Biochemical and Biophysical Research Communications 2005; 331: 285-294.
41. Matsumoto M, Funami K, Tanabe M et al. Subcellular localization of toll-like receptor 3 in human dendritic cells. The Journal of Immunology 2003; 171: 3154-3162.
42. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
43. Leifer CA, Kennedy MN, Mazzoni A et al. TLR9 is localized in the endoplasmic reticulum prior to stimulation. The Journal of Immunology 2004; 173: 1179-1183.
44. Leifer CA, Brooks JC, Hoelzer K et al. Cytoplasmic targeting motifs control localization of toll-like receptor 9. The Journal of Biological Chemistry 2006; 281: 35585-35592.
45. Hemmi H, Takeuchi O, Kawai T et al. A toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-745.
46. Meier A, Kirschning CJ, Nikolaus T et al. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cellular Microbiology 2005; 5: 561-570.
47. Roeder A, Kirschning CJ, Rupec RA et al. Toll-like receptors are key mediators in innate antifungal immunity. Medical Mycology 2004; 42: 485-498.
48. Suri SS, Janardhan KS, Parbhakar O et al. Expression of toll-like receptor 4 and 2 in horse lungs. Veterinary Research 2006; 37: 541-551.
49. Johnson AC, Henizel FP, Diaconu E et al. Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation. Investigative Ophthalmology &Visual Science 2005; 46: 589-595.